A citation-based method for searching scientific literature

Katherine J Kunkel, Alejandro Lemor, Shazil Mahmood, Pedro Villablanca, Harish Ramakrishna. J Cardiothorac Vasc Anesth 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing.
Cai Liu, Yifan Zhang, Weili Chen, Youming Lu, Wei Li, Yongqiang Liu, Xiaojuan Lai, Yanchun Gong, Xuefang Liu, Yongguo Li,[...]. Eur J Pharm Sci 2019
10
100


Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
600
100



Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.
Dorota Danielak, Marta Karaźniewicz-Łada, Anna Komosa, Paweł Burchardt, Maciej Lesiak, Łukasz Kruszyna, Agnieszka Graczyk-Szuster, Franciszek Główka. Eur J Clin Pharmacol 2017
19
100

Clinical pharmacokinetics and pharmacodynamics of clopidogrel.
Xi-Ling Jiang, Snehal Samant, Lawrence J Lesko, Stephan Schmidt. Clin Pharmacokinet 2015
88
100

Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
Miho Kazui, Yumi Nishiya, Tomoko Ishizuka, Katsunobu Hagihara, Nagy A Farid, Osamu Okazaki, Toshihiko Ikeda, Atsushi Kurihara. Drug Metab Dispos 2010
569
100

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.
Craig R Lee, Jasmine A Luzum, Katrin Sangkuhl, Roseann S Gammal, Marc S Sabatine, Charles Michael Stein, David F Kisor, Nita A Limdi, Yee Ming Lee, Stuart A Scott,[...]. Clin Pharmacol Ther 2022
7
100


Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.
Radojka M Savic, Daniël M Jonker, Thomas Kerbusch, Mats O Karlsson. J Pharmacokinet Pharmacodyn 2007
345
100


CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.
Michael V Holmes, Pablo Perel, Tina Shah, Aroon D Hingorani, Juan P Casas. JAMA 2011
353
100

Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients.
Nicolas Simon, Jonathan Finzi, Guillaume Cayla, Gilles Montalescot, Jean-Philippe Collet, Jean-Sébastien Hulot. Eur J Clin Pharmacol 2015
13
100

Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects.
T Simon, D L Bhatt, L Bergougnan, C Farenc, K Pearson, L Perrin, E Vicaut, F Lacreta, F Hurbin, M Dubar. Clin Pharmacol Ther 2011
55
100

Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
Cai Liu, Youming Lu, Hongbin Sun, Jin Yang, Yongqiang Liu, Xiaojuan Lai, Yanchun Gong, Xuefang Liu, Yongguo Li, Yifan Zhang,[...]. J Pharm Biomed Anal 2018
12
100

Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
Marta Karaźniewicz-Łada, Dorota Danielak, Paweł Burchardt, Lukasz Kruszyna, Anna Komosa, Maciej Lesiak, Franciszek Główka. Clin Pharmacokinet 2014
64
100

Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.
Xi-Ling Jiang, Snehal Samant, Joshua P Lewis, Richard B Horenstein, Alan R Shuldiner, Laura M Yerges-Armstrong, Lambertus A Peletier, Lawrence J Lesko, Stephan Schmidt. Eur J Pharm Sci 2016
15
100

A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity.
Mai Shimizu, Tatsuki Fukami, Yuki Kobayashi, Masataka Takamiya, Yasuhiro Aoki, Miki Nakajima, Tsuyoshi Yokoi. Drug Metab Dispos 2012
25
100

Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans.
Jinfang Jiang, Xiaoyan Chen, Dafang Zhong. Front Pharmacol 2017
14
100

Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12 inhibitor.
Yifan Zhang, Xiaoxue Zhu, Yan Zhan, Xiaojiao Li, Cai Liu, Yunting Zhu, Hong Zhang, Haijing Wei, Yu Xia, Hongbin Sun,[...]. Br J Clin Pharmacol 2020
9
100

Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
Lingling Chen, Shengying Qin, Jing Xie, Jimin Tang, Lun Yang, Wen Shen, Xinzhi Zhao, Jing Du, Guang He, Guoyin Feng,[...]. Pharmacogenomics 2008
75
100

Effect of high-dose clopidogrel according to CYP2C19*2 genotype in patients undergoing percutaneous coronary intervention- a systematic review and meta-analysis.
Lanning Zhang, Jie Yang, Xiaoquan Zhu, Xuyun Wang, Li Peng, Xiaoqi Li, Peng Cheng, Tong Yin. Thromb Res 2015
30
100

The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
Yukio Ishizawa, Norio Yasui-Furukori, Takenori Takahata, Mutsuo Sasaki, Tomonori Tateishi. Clin Pharmacokinet 2005
53
100





Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.
Richard B Horenstein, Rajnikanth Madabushi, Issam Zineh, Laura M Yerges-Armstrong, Cody J Peer, Robert N Schuck, William Douglas Figg, Alan R Shuldiner, Michael A Pacanowski. J Clin Pharmacol 2014
27
100

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.
Justin J Wilkins, Radojka M Savic, Mats O Karlsson, Grant Langdon, Helen McIlleron, Goonaseelan Pillai, Peter J Smith, Ulrika S H Simonsson. Antimicrob Agents Chemother 2008
109
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.